Bionano Genomics (BNGO) Amortization of Deferred Charges (2021 - 2022)
Bionano Genomics (BNGO) reported Amortization of Deferred Charges of -$383000.0 for Q4 2022, down 286.83% on a YoY basis from $205000.0 in Q4 2021, and down 932.61% sequentially from $46000.0 in Q3 2022.
Bionano Genomics (BNGO) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends
Bionano Genomics (BNGO) has 2 years of Amortization of Deferred Charges data on file, last reported at -$383000.0 in Q4 2022.
- For the quarter ending Q4 2022, Amortization of Deferred Charges fell 286.83% year-over-year to -$383000.0; the trailing twelve-month figure through Sep 2022 stood at $588000.0 (changed N/A YoY), and the FY2021 full-year result was $205000.0, down 83.78% from the prior year.
- Amortization of Deferred Charges retreated to -$383000.0 in Q4 2022, from $46000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $299000.0 in Q1 2022 to a low of -$383000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.11 Bn | 121.89 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.80 Bn | 43.99 Bn | 2.15 Bn |
| 3 | Alcon | 33.03 Bn | 31.37 Bn | 1.53 Bn |
| 4 | Medline | 32.85 Bn | 30.62 Bn | 1.84 Bn |
| 5 | Resmed | 29.39 Bn | 27.73 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.33 Bn | 22.89 Bn | 329.20 Mn |
| 7 | Solventum | 14.11 Bn | 13.55 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn |
| 10 | Bionano Genomics | 12.08 Mn | -1.62 Mn | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -383,000.00 |
| Dec 31, 2022 | -383,000.00 |
| Sep 30, 2022 | 46,000.00 |
| Sep 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 38,000.00 |
| Jun 30, 2022 | 38,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 205,000.00 |
| Dec 31, 2021 | 205,000.00 |